InvestorsHub Logo
Followers 34
Posts 3178
Boards Moderated 0
Alias Born 10/20/2012

Re: ADVFN_curncman post# 57804

Friday, 04/21/2023 11:30:40 AM

Friday, April 21, 2023 11:30:40 AM

Post# of 64825
by TimGDixon » Fri Apr 21, 2023 9:12 am

Codycrusher wrote: ?Fri Apr 21, 2023 9:11 am
TimGDixon wrote: ?Fri Apr 21, 2023 8:22 am
No that IND is in process and we have placed it with Breathe. We will supplement Breathe with phase 3 data from ARDS and before actually starting phase 1/2b upgrade to phase 3 - watch.
cablejohn45 wrote: ?Fri Apr 21, 2023 8:18 am
Tim is TSOI going to file again for a new IND for COPD?
-- On the 23rd of May we announced receiving IND number 28508 from the FDA for our proposed clinical trial evaluating the JadiCell in treatment of COPD. --

context;
"On May 02 we reported launching the Phase III Trial. A week later on the 9th we announced filing of a new IND seeking permission to treat 10 patients with advanced COPD using JadiCell. On May 12th we told you about new data demonstrating enhancement of the therapeutic activities of the JadiCell through induction of a specific cell type called myeloid derived progenitor cells. On the 23rd of May we announced receiving IND number 28508 from the FDA for our proposed clinical trial evaluating the JadiCell in treatment of COPD."
from;
So are you saying that you are going to use the data from phase 3 once it’s completed and upgrade breath biologics, that is for COPD and upgrade it to a instant phase 3 once phase 3 ARDS is done and commercialized? That would be HUGEEEE
Thats what I am saying... breathe becomes phase 3 clinical stage co.


Cable

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News